8th Annual Next Generation Nicotine Delivery USA

Join key business leaders from the FDA, ENDS and tobacco industry across the US market to explore actionable strategies to facilitate legal compliance and commercial success.

3 - 4

June

2026
  • Hyatt Regency Miami
  • Ticketed
  • Why attend?
  • Agenda
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • Sponsors
  • Media Centre
  • Contact Us

Sponsors Include

Back

Company Information

Zanoprima is a manufacturer of S-nicotine. The company has developed a novel enzymatic process for the production utilizing “green chemistry”,  yielding a significant carbon emission reduction and other ESG benefits when compared to plant extraction.  These processes are subject to granted patents in over 40 countries. Zanoprima supports manufacturers in regulatory submissions, through a Drug Master File (DMF) and Tobacco Product Master File (TPMF) on file with the US Food and Drug Administration. Further, Zanoprima has developed improved reduced risk nicotine products using this high purity S-nicotine, including next generation Nicotine Replacement Therapies, with patents granted for novel vaping and oral products.

Company Website

To learn more, please visit our website - https://www.zanoprima.com/

Next Sponsor
Back

Company Information

Accorto Regulatory Solutions provides specialized regulatory and compliance guidance to companies bringing innovative tobacco harm reduction products to the U.S. market. With deep experience supporting global clients, we help navigate the complex U.S. regulatory landscape through strategic insight, technical expertise, and full-spectrum FDA compliance support. Our services include PMTA development and submission, regulatory risk assessments, scientific substantiation, and long-term compliance planning for products like nicotine pouches, ENDS, heat-not-burn devices, and novel oral nicotine products (ONPs).

Our expert team, comprising of regulatory specialists, scientists, and former FDA professionals, brings unmatched experience to every project. Driven by a belief in science-based solutions, we ensure our clients’ products meet FDA standards while building a defensible path to authorization. We support responsible companies committed to offering reduced-risk alternatives for adult smokers and stay closely aligned with evolving FDA policy to keep our clients prepared, proactive, and ahead of the curve. We’re not just regulatory advisors; we’re partners in your mission to deliver credible alternatives to combustible tobacco.

Company Website

To learn more, please visit our website - www.accortoreg.com

Next Sponsor
Back

Company Information

Reynolds American Inc., the BAT Group’s U.S. subsidiary, and its operating companies are leading the transformation of the tobacco and nicotine industry. Our purpose is to create A Better Tomorrow™ by Building a Smokeless world. Our strategic aim is to migrate smokers from cigarettes to smokeless alternatives and become a predominantly smokeless business by 2035.

Company Website

To learn more, please visit our website - www.reynoldsamerican.com

Next Sponsor
Back

Company Information

Broughton is a Contract Research Organisation (CRO) with over 10 years’ experience delivering analytical, scientific and regulatory services for the ENDS industry. Our team of scientists, toxicologists and regulatory experts are generating data and managing client projects in areas including US PMTA strategy and delivery, EU TPD submissions and Medicinal Product strategy and applications. Our 20,000ft2 CRO facility in the UK incorporates several specialist laboratories equipped with the latest aerosol collection instruments, high-spec analytical equipment and fully validated data management systems.

Company Website

To learn more, please visit our website - http://www.broughton-group.com

Next Sponsor
Back

Company Information

Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and therapeutic areas such as neuroscience, substance abuse, pain, tobacco harm reduction, infectious diseases and many others. CRO services include project management, data management, biostatistics, statistical programming, PK/PD analysis, medical writing, monitoring, site feasibility and management for multi-site trials.

Company Website

To learn more, please visit our website - www.drvince.com/cro/

Next Sponsor
Back

Company Information

AgeChecker.Net is the leading provider in online age verification for age-restricted industries. Our system is designed to prevent underage sales and comply with federal, state and local regulations.

Company Website

To learn more, please visit our website - www.agechecker.net

Next Sponsor
Back

Company Information

The Law Office of Moffa, Sutton, & Donnini, PA, focuses primarily on state and local taxes, including Florida sales tax, tobacco tax and motor fuel taxes. We have defended businesses against state agencies, including the Florida Department of Revenue, since 1991. Our firm has offices in Fort Lauderdale, Tampa, and Tallahassee.

Company Website

To learn more, please visit our website - https://www.floridasalestax.com/

Next Sponsor
Back

Company Information

Sanova provides comprehensive regulatory, scientific, and litigation consulting services for regulated tobacco products. We offer full-service PMTA, MRTPA, SE, TPMF, and TPSAC support, and cost-sharing programs for literature reviews, ingredient assessments, and nationally representative survey analytics. Our experts have extensive FDA CTP experience and a strong history of delivering results.

Company Website

To learn more, please visit our website - www.sanova.co

Next Sponsor
Back

Company Information

Adroit offers best-in-class TPMF-Registered Nicotine EP/USP and its derivatives with NEAR-ZERO IMPURITIES, ideal for pharmaceuticals, e-liquids, vapes, nicotine pouches, and other NRT products. Our proprietary purification and distillation processes identify, isolate, and eliminate impurities at ppm and ppb levels, ensuring superior stability, neutral aftertaste, clear color, and mild odor. Innovative and ESG-compliant manufacturing ensures our products are sustainable and meet stringent quality control standards that well exceeds US & European Pharmacopeia.

Company Website

To learn more, please visit our website - www.adroitnaturals.com

Next Sponsor
Back
Next Sponsor
Back

Company Information

Providing a Synthetic Tabacco free product in both the RS and S form.

Company Website

To learn more, please visit our website - www.nicotexlabs.com

Next Sponsor
Back

Company Information

Nordson Measurement & Control Solutions is a leading global provider of gauging systems for the tobacco industry. The TM9000 on-line gauge measures moisture, color, basis weight, sugars, nicotine, and humectants accurately and without interference from ambient lighting, temperature, humidity, or tobacco pass height. On the other hand, the InfraLab Series 9 analyzer measures samples in less than 5 seconds and is suitable for both laboratory and at-line use.

Company Website

To learn more, please visit our website - https://www.ndc.com/food-bulk-materials-processing/choose-your-industry/tobacco/reduced-risk-and-other-tobacco-solutions/

Next Sponsor
Back

Company Information

IKE is setting the standard for product security and safety through advanced biometric device pairing, blockchain data protection and integrated BLE technology. Our next generation platform and world-class partnerships deliver a robust, reliable solution for age-verification and authentication across product categories using a single, easy-to-use mobile app.

Company Website

To learn more, please visit our website - www.iketech.com

Next Sponsor
Back

Company Information

MANE is a well-respected name in the Flavour and Fragrance industry for more than 150 years. With the family’s fifth generation joining the business, MANE Group operates in close to 40 countries, with 29 manufacturing sites and 50 R&D centers. For the tobacco industry, MANE Group has at its disposal a dedicated department to provide value chain services from R&D to the commercialization of products. The department offers all traditional flavors for cigarettes, RYO, shishas, snus, etc. For over 15 years, the company has also focused on new technology applications in its portfolio for e-cigarettes, heat-not-burn, and new delivery systems like encapsulation. MANE’s tobacco business unit consisting of 5 laboratories located around the world and more than 20 specialists works closely with its customers. The core business is customer-focused flavor creation. The unit designs flavors according to the needs of the customers by guiding them in line with new trends in the market. www.mane.com

Company Website

To learn more, please visit our website - www.mane.com

Next Sponsor
Back

Company Information

AmeriNic is a leading producer of liquid nicotine in the U.S. for electronic nicotine delivery systems. We produce only pure United States Pharmacopeia (USP) nicotine—clean, clear and consistent, batch to batch.
Our nicotine exceeds USP standards and is manufactured in our FDA compliant (cGMP) facility utilizing some of the most robust production controls and quality systems in the industry. We proudly manufacture AmeriNic in the USA.
AmeriNic offers competitive pricing, provides stellar customer service, and maintains ample reserve inventory to ensure that we consistently meet the needs of our customers.
If you seek a top quality product and a reliable supply of pure nicotine, insist on AmeriNic nicotine for your vapor and e-juice products.

Company Website

To learn more, please visit our website - www.ameri-nic.com

Next Sponsor

    Why attend?

    The 8th Next Generation Nicotine Delivery Conference is due to take place 3-4 June 2026 in Downtown Miami.

    Keep up-to-date with the latest developments, challenges, and breakthroughs in nicotine research and public health through keynote presentations, panel discussions, roundtable discussions and dynamic networking sessions.

    WHAT TO EXPECT FOR 2026?

    The leading event to connect the nicotine industry to drive a strong future in tobacco and nicotine derived products by aligning strategic priorities to achieve new heights in consumer reach and profitability.

    150+

    Attendees

    		15+

    Exhibitors

    		80%

    Attendees at Director+ level
    150+

    Attendees

    		15+

    Exhibitors
    80%

    Attendees at Director+ level

    Testimonials

    Agenda

    • 3 Jun 2026
    • 4 Jun 2026
    Expand All

    7:30 AM

    Registration and Networking

    8:50 AM

    Chairman’s Opening Remarks

    Speakers

    Angela Ho-Chen
    Managing Counsel – Regulatory, Reynolds American

    9 AM

    Keynote: FDA Update – Key Changes to Organizational Structure and Regulatory Policies

    • CTP organizational changes
    • Update on PMTA applications
    • Products that pose public health risks and outweigh potential benefits for consumers
    • Working towards reduced-risk products while still focusing on enforcement

    10 AM

    Lead Sponsor: Available for Sponsorship

    10:30 AM

    Panel Discussion: Building a Strong and Effective Working Relationship With CTP

    Panelist 1: Brand Insight

    Panelist 2: Brand Insight

    Panelist 3: Available for Sponsorship

    11 AM

    Morning Refreshments and Networking

    11:30 AM

    Reserved for Accorto

    Speakers

    Dr. Vince Angelico
    Chief Science Officer, Accorto Regulatory Solutions

    12 PM

    Case Study: Brand Insights – Heated Tobacco

    • Dual-flavor capsules for heated tobacco

    12:20 PM

    Reserved for ARAC

    Speakers

    Dr. Jessica Zdinak
    Founder & Chief Research Officer, Applied Research and Analysis Company (ARAC)

    12:50 PM

    Lunch and Networking Sponsored by AmeriNic

    1:50 PM

    Reserved for Dr. Vince Clinical Research

    Speakers

    George Hardie
    VP of Clinical Development, Dr. Vince Clinical Research

    2:20 PM

    Case Study: Brand Insights – Innovation in Vaping Products

    2:40 PM

    Reserved for Broughton

    Speakers

    Chris Allen
    Chief Executive Officer, Broughton

    3:10 PM

    Case Study: Brand Insights – Nicotine Pouches

    3:30 PM

    Afternoon Refreshments and Networking

    4 PM

    Reserved for Troutman Pepper Locke

    4:30 PM

    Panel Discussion: How Are Illicit Products Being Dealt With Globally

    • How can tobacco companies work with regulators and combat the illicit market
    • Law enforcement initiatives
    • The US Customs and Border Protection (CBP) - latest developments

    Panelist 1: Brand Insight

    Panelist 2: Brand Insight

    Panelist 3: Sarah Marking, Co-Founder and Chief Strategy Officer, Sanova

    Speakers

    Sarah Marking, MS
    Co-Founder and Chief Strategy Officer, Sanova

    5 PM

    Spotlight: Reserved for AgeChecker.net

    Speakers

    Matt Fields
    Vice President, AgeChecker.Net

    5:15 PM

    Shark Tank

    Each company will provide a 1-minute elevator pitch to showcase their innovations.

    5:30 PM

    Reserved for CenExcel

    Speakers

    Deanna Friedrich
    Vice President of Corporate Development - Healthcare, Clinical Research, CenExcel

    5:45 PM

    Chairman’s Closing Remarks

    Speakers

    Angela Ho-Chen
    Managing Counsel – Regulatory, Reynolds American

    5:50 PM

    Drinks Reception Hosted by CenExcel

    7:30 PM

    End of Day One

    7:30 AM

    Registration and Networking

    8:50 AM

    Chairman’s Opening Remarks

    Speakers

    Angela Ho-Chen
    Managing Counsel – Regulatory, Reynolds American

    9 AM

    Keynote: FDA Update – Best Practice Guidelines

    • Submitting PMTA applications
    • Working with the FDA
    • FDA’s vision of best practice: how to work effectively with industry to ensure safe and enjoyable products for consumers

    10 AM

    Available for Sponsorship

    10:30 AM

    Morning Refreshments, Networking and Prize Draw

    Delegates will enter a draw to win prizes.

    11 AM

    Panel Discussion: Harm Reduction in Practice

    • Regulatory responses aimed at curbing underage use
    • Innovative solutions that prevent underage use

     

     

    Panelist 1: Brand Insight

    Panelist 2: Brand Insight

    Panelist 3: Available for Sponsorship

    11:30 AM

    Available for Sponsorship

    11:50 AM

    Case Study: Brand Insights – Oral Nicotine

    12:10 PM

    Available for Sponsorship

    12:30 PM

    Lunch and Networkin Sponsored by AmeriNicg

    1:30 PM

    Speaker Hosted Roundtables

    Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

    Each roundtable session lasts for 40 minutes, and delegates may attend up to 2 roundtables. 

    Roundtable 1: Reserved for Lead Sponsor

    Roundtable 2: Reserved for Accorto

    Roundtable 3: Hosted by Angela Ho-Chen, Managing Counsel – Regulatory, Reynolds American

    Speakers

    Angela Ho-Chen
    Managing Counsel – Regulatory, Reynolds American

    2:50 PM

    Afternoon Refreshments and Networking

    3:20 PM

    Fireside Chat: Tax Update

    3:40 PM

    Panel Discussion: What’s Next in Innovation for Next Generation Nicotine

    • Advancements in nicotine delivery systems and capsule technology
    • Next-generation packaging solutions
    • The role of next-generation nicotine products in tobacco harm reduction - how these products can help adult smokers switch away from combustible cigarettes

     

    Panelist 1: Brand Insight

    Panelist 2: Brand Insight

    Panelist 3: Available for Sponsorship

    4:10 PM

    Chairman’s closing remarks

    Speakers

    Angela Ho-Chen
    Managing Counsel – Regulatory, Reynolds American

    4:15 PM

    End of conference

    Speakers

    Select a speaker to learn more

    Back
    Angela Ho-Chen
    Managing Counsel – Regulatory, Reynolds American

    Angela Ho-Chen is currently a Managing Counsel at RAI Services. Angela received her Bachelor of Arts degree from Emory University, her Master of Public Health in Cancer Epidemiology and Biostatistics and Master of Public Administration from the University of Miami, and her Juris Doctorate from American University.

    Angela’s career has spanned nearly 20 years in the medical device and tobacco regulatory arenas. Angela is an attorney and practiced criminal food and drug law as outside counsel prior to transitioning into FDA’s Center for Devices and Radiological Health (CDRH) where she leveraged her Master of Public Health degree to take a role as a Consumer Safety Officer in the Office of Compliance. In her 15 months at CDRH, Angela worked on several task forces and served as an acting case expert. In January 2010, Angela took a Regulatory Counsel position at the Center for Tobacco Products (CTP). Angela was one of the founding members of the Office of Compliance and Enforcement at CTP and left CTP in February of 2017 as Division Regulatory Counsel. She then transitioned into the legal and regulatory departments at Altria Client Services and Juul Labs prior to establishing her own consulting firm, FDA Regulatory and Legal Services, PLLC.

    Angela has extensive cross-functional regulatory and legal leadership and project management experience. Her legal and regulatory review portfolio specifically includes pre-market and post-market regulatory submissions strategy and execution, gap analyses, marketing and labeling reviews, inspection/audit readiness, compliance analyses and enforcement mitigation in medical devices and tobacco. Angela has assisted clients with interpreting the Food, Drug, and Cosmetic Act (FDCA), the Family Smoking Prevention and Tobacco Control Act (TCA), their implementing regulations as well as other federal agencies’ statutes.

     

    Session Details:

    Chairman’s Closing Remarks

    2026-06-03, 5:45 PM

    Session Details:

    Chairman’s Opening Remarks

    2026-06-03, 8:50 AM

    Session Details:

    Speaker Hosted Roundtables

    2026-06-04, 1:30 PM

    Session Details:

    Chairman’s Opening Remarks

    2026-06-04, 8:50 AM

    Session Details:

    Chairman’s closing remarks

    2026-06-04, 4:10 PM

    View In Agenda
    Next speaker
    Back
    Benjamin Apelberg
    Ph.D, Deputy Director for Regulatory Science in the Office of Science, FDA’s Center for Tobacco Products (CTP)

    Benjamin Apelberg, PhD is the Deputy Director for Regulatory Science in the Office of Science at FDA’s Center for Tobacco Products (CTP). In this role, he oversees scientific divisions responsible for managing the Office’s tobacco regulatory science research program, including the Population Assessment of Tobacco and Health (PATH) study and collaboration with CDC on the National Youth Tobacco Survey; serving as expert reviewers and technical project leads (TPLs) for the premarket tobacco product application (PMTA) and modified risk tobacco product application (MRTPA) pathways; and providing scientific expertise in the fields of the health sciences, medicine, pharmacology, epidemiology, social science, evaluation, and statistics to support the Center’s tobacco product regulatory efforts.

    Next speaker
    Back
    Anand Ashok
    Chief Executive Officer, Zanoprima Lifesciences
    Next speaker
    Back
    Dr. Vince Angelico
    Chief Science Officer, Accorto Regulatory Solutions

    Dr. Vincent Angelico is a co-founder of Accorto Regulatory Solutions and serves as its Chief Science Officer. In this role, Vince spends most of his time working with clients to formulate cost effective and successful regulatory strategies that meet client and FDA expectations.  Prior to joining Accorto, Vince was a senior executive at Blackbriar Regulatory Services, where he provided scientific and regulatory consulting to several alternative nicotine products companies and developed the regulatory strategy for Avail Vapor LLC, which ultimately submitted some of the few pre-market applications that the FDA did not reject in this constantly changing newly regulated market.  Vince developed his professional career working in the in the pharmaceutical industry, starting out as research and development chemist at Merck & Co Pharmaceuticals.  While at Merck, Vince helped develop products in the new drug pipeline and moved through the ranks to become a product development team leader.  His work led to regulatory filings on the notable cholesterol regulating drug ZOCOR™ (simvastatin).  Vince later worked for the German based pharmaceutical company Boehringer Ingelheim (BI), where he was assigned to their active ingredient manufacturing site in Petersburg Virginia.  Vince served in several different leadership roles for BI before ultimately becoming the Director of Manufacturing Operations in 2012.  Vince holds a BS in Chemistry from Virginia Commonwealth University and a Ph.D. in Analytical Chemistry from the University of Arizona.

    Session Details:

    Reserved for Accorto

    2026-06-03, 11:30 AM

    View In Agenda
    Next speaker
    Back
    David Lawson
    Founder & Chief Executive Officer, Inter Scientific

    David is a leading regulatory expert in nicotine-containing products, with over 15 years of experience across the pharmaceutical and tobacco sectors. He played a pivotal role in the approval of e-VOKE, the world’s first medically licensed e-cigarette, and has since been instrumental in shaping regulatory strategies for next-generation nicotine products.

    David’s cross-sector expertise spans product development, toxicological assessment, and global regulatory compliance, with a focus on supporting manufacturers through complex submissions such as Premarket Tobacco Product Applications (PMTAs). His multidisciplinary background enables him to bridge scientific, legal, and commercial perspectives in regulatory decision-making.

    David holds a BSc. (Hons) in Biochemistry, an LLB in Law, and a Master of Business Administration (MBA). He is a qualified medical toxicologist and a Fellow of The Organisation for Professionals in Regulatory Affairs (TOPRA).

    Next speaker
    Back
    Chris Allen
    Chief Executive Officer, Broughton

    Chris co-founded Broughton in 2006, having worked previously within global blue-chip pharmaceutical companies and Contract Research Organisations within the medicinal product and medical device sectors.

    • Over 25 years’ experience in Analytical and Regulatory Science focussing on inhaled and solid dose pharmaceuticals, medical devices, and nicotine products
    • Extensive experience with global regulatory agencies, including US Food and Drug Administration (FDA) and UK Medicines and Healthcare products Regulatory Agency (MHRA)
    • Oversees the overall direction of the organisation, ensuring that Broughton’s mission is achieved
    • Has a passion for developing Broughton’s services and team members to help accelerate life-enhancing products to market

    Chris Allen is the Chief Executive Officer at Broughton. Since obtaining a Bachelor of Science degree in Chemistry and a subsequent Post Graduate Certificate in Analytical Science, he has gained over 25 years of analytical and regulatory experience working in global medical device and pharmaceutical companies and leading CROs. Chris started his career working on both Medical Devices and Pharmaceutical products within Smith+Nephew. Subsequently, Chris moved into inhaled medicines, supporting blue-chip pharmaceutical companies’ drug product registration programs within Melbourn Intertek.

    Before co-founding Broughton, Chris moved into a leadership role with Sciantec (Cawood), successfully overseeing its entry into the Veterinary Medicines market, supporting global Marketing Authorizations and site inspections.

    Chris co-founded Broughton Laboratories in 2006, with Paul Moran, overseeing its first and successful MHRA Good Manufacturing Practice (GMP) inspection within the first three months. With a focus on supporting Marketing Authorizations and Post Marketing activities within the pharmaceutical sector, Broughton played a pivotal role in obtaining the first UK Medicinal License for an electronic cigarette, a project that started in 2010.

    Chris took this combined experience of Pharmaceuticals and Nicotine to expand Broughton’s services to support the development and registration of Reduced-Risk Tobacco Products, including Electronic Nicotine Delivery Systems (ENDS). Rapid growth within this area resulted in the expansion to a second site, and a multi-million-pound (GBP) investment into a custom-built facility, leading-edge analytical equipment and expansion of the team and service offerings. Chris has overseen multiple product applications for Medicinal Marketing Authorization Applications (MAA), EU Tobacco Products Directive (TPD), US Premarket Tobacco Product Application (PMTA) and other global markets. Chris has become well established as a recognized subject matter expert in the science and regulation of pharmaceuticals, medical devices and reduced risk nicotine products.

    As Chief Executive Officer of Broughton, Chris’ passion lies in developing the Broughton Team and associated services to deliver life-enhancing products to market for their clients.

    Session Details:

    Reserved for Broughton

    2026-06-03, 2:40 PM

    View In Agenda
    Next speaker
    Back
    Azim Chowdhury
    Partner, Keller and Heckman

    Azim Chowdhury, a partner with the law firm of Keller and Heckman LLP, counsels domestic and foreign corporations on U.S. Food and Drug Administration (FDA) and international regulatory compliance matters and on tobacco and e-vapor product regulation.

    Mr. Chowdhury advises corporations in establishing clearances for food and drug additives in the U.S., Canada, and European Union, with an emphasis on indirect additives used in drug and food-contact materials. He has expertise in the tobacco and e-vapor product regulation relating to the implementation of the Family Smoking Prevention and Tobacco Control Act and spearheads the FDA Tobacco and Electronic Cigarette practice at Keller and Heckman LLP. 

    Mr. Chowdhury has experience representing tobacco, e-cigarette and e-liquid manufacturers, suppliers and trade associations in matters of FDA regulatory and corporate compliance. He represents clients on tobacco, e-cigarette and e-liquid matters before the FDA and the Consumer Product Safety Commission (CPSC). He is also a frequent contributor to the Food and Drug Law Institute (FDLI) Update Magazine, has served on the Editorial Advisory Board of the Food and Drug Law Journal, and edited and co-authored FDLI’s recent publications, Tobacco Regulation and Compliance: An Essential Resource and FDA Regulation of Tobacco: A Comprehensive Guide – An FDLI Primer. Mr. Chowdhury is a frequent speaker and author.

    Next speaker
    Back
    Dr. Jessica Zdinak
    Founder & Chief Research Officer, Applied Research and Analysis Company (ARAC)

    Dr. Jessica Zdinak is an Eastern Shore of Virginia native who received a B.S. in Psychology from Christopher Newport University, and a M.S. and Ph.D. in Experimental Psychology & Statistics from Oklahoma State University. Dr. Zdinak has dedicated 20 years working as a behavioral scientist in a variety of settings, including academic, federal government, public health, and industry, and now serves as Chief Research Officer of a leading U.S. based Contract Research Organization, ARAC. 

    Her team services both U.S. and International clients in their product development and consumer research supporting innovation and “next generation” products, with a focused expertise on the regulatory sciences for U.S. applications including: ITPs, PMTAs, MRTPAs, SEs, 510(k), and Breakthrough Designations. 

    The ARAC firm specializes in providing boutique-level personalized research services, combining their expertise in psychology, statistics, and behavior change, with a focus on the consumer, and the role of the regulator. Their triangular approach has proven successful across a variety of studies, including label development and comprehension, human factors/usability, clinical behavioral studies, specifically randomized experimental trials, TPPI, and post-market surveillance systems.

    Session Details:

    Reserved for ARAC

    2026-06-03, 12:20 PM

    View In Agenda
    Next speaker
    Back
    Collin Gerringer
    Senior Study Manager Dr. Vince Clinical Research
    Next speaker
    Back
    Ajesh Raju
    Senior Project Manager Dr. Vince Clinical Research
    Next speaker
    Back
    Matt Fields
    Vice President, AgeChecker.Net

    Matt Fields is the Vice President of AgeChecker.Net, a leading provider of online age verification solutions for retail and ecommerce businesses. Based in Westlake Village, California, Fields has played a pivotal role in developing and scaling the company’s technology to help retailers comply with age-restricted sales laws while enhancing user experience and data security.

    Fields has also emphasized the importance of regulatory compliance and social responsibility in ecommerce. He highlighted the company's commitment to replacing outdated “age gate” methods with real-time verification using public records and secure ID uploads, ensuring that businesses avoid underage sales without disrupting the customer experience.

    With a focus on innovation and adaptability, Fields continues to lead AgeChecker.Net in expanding its integrations across ecommerce platforms and enhancing its fraud prevention capabilities, positioning the company as a trusted partner in the rapidly evolving landscape of online age-restricted commerce.

    Session Details:

    Spotlight: Reserved for AgeChecker.net

    2026-06-03, 5:00 PM

    View In Agenda
    Next speaker
    Back
    Sarah Marking, MS
    Co-Founder and Chief Strategy Officer, Sanova

    Sarah has broad experience serving pharma, medical device, and consumer products industries, with a focus on integrating science, quality processes, and business goals in a regulated environment. She has a proven ability to develop resilient, cross-functional teams and champion complex projects across diverse groups of stakeholders. Sarah specializes in helping clients develop and successfully execute strategies to access the U.S. market.

    Sarah works closely with clients to plan and submit premarket tobacco product applications (PMTAs) and modified risk tobacco product applications (MRTPAs) across various nicotine product categories, including novel, emerging delivery systems. She combines her extensive industry experience, scientific expertise, and business acumen to navigate the rapidly evolving regulatory landscape and provide practical solutions to regulatory challenges. Sarah supports regulatory strategy across all scientific areas including product design and development, manufacturing, and nonclinical and clinical study programs.

    She specializes in helping clients create and navigate multi-product regulatory strategies and product line extensions. These strategies leverage existing scientific evidence through use of supplemental PMTAs (sPMTAs) and tobacco product master files (TPMFs) to minimize regulatory costs and timelines. She also supports preparation for Tobacco Products Scientific Advisory Committee (TPSAC) meetings.

    Session Details:

    Panel Discussion: How Are Illicit Products Being Dealt With Globally

    2026-06-03, 4:30 PM

    View In Agenda
    Next speaker
    Back
    Deanna Friedrich
    Vice President of Corporate Development - Healthcare, Clinical Research, CenExcel

    Session Details:

    Reserved for CenExcel

    2026-06-03, 5:30 PM

    View In Agenda
    Next speaker
    Back
    Bryan Haynes
    Partner, Troutman Pepper Locke

    Bryan Haynes is an experienced attorney at Troutman Pepper Locke, specializing in regulatory compliance and enforcement within the tobacco industry. As a key member of the firm's Regulatory Investigations, Strategy + Enforcement (RISE) Practice Group and head of the Tobacco + Nicotine practice, he adeptly assists clients in navigating complex regulatory landscapes. Bryan's expertise spans FDA requirements, tobacco taxation, and administrative disputes. He has been instrumental in advising on the Family Smoking Prevention and Tobacco Control Act and the FDA's deeming rule. A skilled litigator, Bryan has successfully represented clients in state and federal courts, ensuring compliance and mitigating risks aligned with business objectives. His comprehensive knowledge and strategic approach make him an invaluable asset to tobacco manufacturers, distributors, retailers, and suppliers.

    Next speaker
    Back
    Agustin E. Rodriguez
    Partner, Troutman Pepper Locke

    Agustin Rodriguez is a seasoned business partner at Troutman Pepper Locke with extensive experience in guiding clients through complex regulatory landscapes in industries such as tobacco, cannabis, and gambling. As a partner in the firm's Regulatory Investigations, Strategy + Enforcement (RISE) Practice Group and its Tobacco + Nicotine and Cannabis law practices, he provides strategic counsel on complex regulatory compliance issues, including licensing, taxation, marketing, and advertising.

    Before joining the firm, Agustin served as Vice President and Associate General Counsel at Altria Group, Inc., where he managed compliance, corporate governance, litigation, and transactional matters globally. Fluent in Spanish and proficient in Portuguese, Agustin has developed compliance programs across Europe, Latin America, Asia, and Africa, addressing risks related to antitrust, anticorruption, the FCPA, and corporate social responsibility.

    Next speaker
    Back
    Katherine Ilkhani
    Co-Ceo, Zolv

    Katherine Ilkhani is an Iranian-American entrepreneur and advocate for climate action, human rights, and public health innovation, evidenced by her previous leadership as Deputy Executive Director at Climate Cardinals, the world's largest youth-led climate nonprofit, and as a member of the National Solidarity Group of Iran, a leading organization within the Iranian diaspora. Her experience also includes contributions to the launch of a digital fashion platform and her role as a youth advisor to Revolve. Currently, she is actively tackling the critical public health and environmental challenge of smoking-related deaths and illicit nicotine products by spearheading the U.S. entry of a revolutionary sustainable nicotine alternative, forging a strategic alliance with a leading Swedish harm reduction company and assembling a world-class regulatory powerhouse to ensure its swift and impactful entry.

    Next speaker
    Back
    Braden Adam
    Co-Ceo, Zolv

    Braden Adam is a software engineer and entrepreneur with a passion for public health, systems thinking, and mission-driven innovation. His experience includes strategic advisory work at Deloitte and over six years of active investment analysis, sharpening his ability to assess risk, navigate uncertainty, and design solutions built for long-term impact. Currently, he is applying this mindset to one of the most tightly regulated and stagnant industries in the U.S., helping lead the introduction of a next-generation nicotine alternative. By assembling a diverse team of regulatory, scientific, and strategic experts, he is working to deliver a product that not only meets the highest standards of compliance and user experience, but also redefines harm reduction for both people and the planet.

    Next speaker
    Back
    Nyah Phengsitthy
    Health Reporter, Bloomberg Law

    Nyah Phengsitthy is a reporter for Bloomberg Law covering the FDA's oversight of the tobacco and pharmaceutical industry. She closely tracks and writes about regulations, litigation, and policies impacting those industries. She's a frequent guest on TV and radio, health podcasts, and panels discussing the government's health care actions. Before joining Bloomberg, she wrote about the impact of COVID-19 on orphanages in Ghana for the Pulitzer Center on Crisis Reporting. She's a graduate of Elon University.

    Next speaker
    Back
    Samy Hamdouche
    Co-founder and COO, Lucy Goods Inc.

    Samy Hamdouche is a co-founder and Chief Operating Officer at Lucy. Prior to Lucy, he helped to build a number of companies in the biopharmaceuticals industry, including Avidity Biosciences and Kura Oncology. He is a scientist by training, and received his Ph.D. in biochemistry and molecular biophysics from Caltech.

    David Renteln is a co-founder and Chief Executive Officer at Lucy. He started Lucy during his attempt to quit smoking, when he first became aware of what is now called the continuum of risk, and the public health potential of reduced harm products. Prior to Lucy, he was a co-founder and Chief Marketing Officer at Soylent, a nutrition and food technology company.

    Next speaker
    Back
    Dr. Charlene Liu, Sc.D.
    President and Chief Scientist, Riskwise Solution LLC.

    Dr. Charlene Liu is a renowned expert in regulatory strategy development and nonclinical studies for tobacco harm reduction products. She brings nearly a decade of leadership experience in toxicology and risk assessment at R.J. Reynolds, JUUL Labs, and RELX International. With nearly 20 years of prior experience in human health risk assessment at Environmental Protection Agency Superfund sites, Dr. Liu was a pioneer in applying quantitative risk assessment (QRA) to evaluate the relative health risks of tobacco harm reduction products over a decade ago. She has successfully developed and applied QRA methodologies for PMTAs and substantial equivalence filings. Her work has influenced the FDA to adopt QRA as a key component in evaluating toxicological risk in ENDS PMTA for regulatory decisions on APPH.
    In 2023, Dr. Liu founded Riskwise Solution, a consulting firm providing expertise in nonclinical science, including chemical characterization, stability, toxicology, and risk assessment, to help clients navigate the evolving PMTA regulatory landscape.

    Next speaker
    Back
    Christopher Russell
    Director, Russell Burnett Research and Consultancy Ltd

    Christopher Russell Ph.D. is the Director of Russell Burnett Research and Consultancy Limited (RBRC), a contract research organization that specializes in the design and conduct of perception, intention, and behavioral studies of tobacco and nicotine products. Studies are designed to obtain information about individuals’ use and perceptions of tobacco and nicotine products; understanding of product labels, labelling, and advertising; and intentions to stop, start, and continue using tobacco and nicotine products. The results of these studies help to inform regulatory assessments of the potential impact of new tobacco products on tobacco use behavior and population health.

    Next speaker
    Back
    Gerald J Donnini II
    Esq., Shareholder, Moffa, Sutton, & Donnini, P.A. & President, Tobacco Tax Refund, Inc

    Gerald "Jerry" Donnini II is a shareholder of the Law Offices of Moffa, Sutton, & Donnini, P.A. He is also president and founder of Tobacco Tax Refund, Inc, which focuses on state tax and licensing issues in the tobacco and vape industry.  Mr. Donnini concentrates in the area of state tax and licensing matters, with a heavy emphasis on the tobacco, convenience store and petroleum industries. He has represented and handled millions of dollars in tobacco and vape tax refunds and assessments for distributors and retailers nationwide.

    Next speaker
    Back
    Derek Yach
    MBChB MPH, Independent Global Health Consultant, Global Health Strategies LLC.

    Derek Yach is a global public health leader with deep experience based on years of work for WHO, leading corporations including PepsiCo, investment funds, academia (as Professor of Global Health at Yale), and not-for-profit organizations such as the Rockefeller and Smoke Free Foundations. His focus in these diverse settings has been to lead initiatives with impact on chronic diseases and their risks, and on mental health. Looking forward, he believes that governments, industry and investors need to give far greater focus to the health of adults as the pandemic recedes if we are to build more resilient and productive populations. He has focused on ways to implement harm reduction strategies within the context of substance abuse, tobacco control and food and nutrition policy. He has degrees in medicine and public health.

    Next speaker
    Back
    Kellsi Booth
    Chief Legal Officer, Black Buffalo

    Kellsi Booth is the Chief Legal Officer at Black Buffalo, Inc., a manufacturer of smokeless tobacco alternatives, where she is responsible for providing strategic direction and practical legal guidance. Kellsi has advised companies at all stages of growth in the nicotine and tobacco space. She is well-versed in regulatory, quality, and policy matters, and previously held a series of progressive roles at Turning Point Brands, Inc. and Juul Labs, Inc. driving key initiatives in these areas. Kellsi is also a leader of trade associations, such as the Coalition of Manufacturers of Smoking Alternatives (CMSA), and co-founded and serves on the board of the Organization of Women in Nicotine and Tobacco (OWNiT).

    Next speaker

    Plan Your Visit

    Venue

    Hyatt Regency Miami

    400 SE 2nd St, Miami, FL 33131, United States

    Book Your Stay

    Sponsors

    Select a sponsor to learn more

    Lead Sponsor

    Featured Sponsor

    Platinum Sponsor

    Gold Sponsors

    Silver Sponsor

    Bronze Sponsors

    Panel Sponsor

    Roundtable Sponsor

    Exhibitors

    Networking Sponsor

    Badge & Lanyard Sponsor

    Day 1 Luncheon Sponsor

    Media Centre

    Nicotine Insider

    Tobacco Reporter

    Become a Media Partner

    Enquiry

    Contact Us

    SPONSORSHIP ENQUIRIES

    Francesco Magli

    Senior Account Manager

    +(44) 020 7947 2735

    SPEAKER ENQUIRIES

    Alfred Mani

    Conference Producer

    +44 (0)20 4540 7582

    MARKETING ENQUIRIES

    Amy King

    Senior Marketing Executive

    SPONSORSHIP ENQUIRIES

    To enquire about sponsorship opportunities for the conference, please contact:

    Francesco Magli

    Senior Account Manager


    +(44) 020 7947 2735

    SPEAKER ENQUIRIES

    To enquire about speaking opportunities for the conference, please contact:

    Alfred Mani

    Conference Producer


    +44 (0)20 4540 7582